as 04-01-2025 4:00pm EST
Founded: | 1987 | Country: | United States |
Employees: | N/A | City: | SAN DIEGO |
Market Cap: | N/A | IPO Year: | 1992 |
Target Price: | $145.00 | AVG Volume (30 days): | 129.6K |
Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.22 | EPS Growth: | N/A |
52 Week Low/High: | $67.72 - $129.90 | Next Earning Date: | 05-06-2025 |
Revenue: | $167,133,000 | Revenue Growth: | 27.28% |
Revenue Growth (this year): | 16.72% | Revenue Growth (next year): | 19.08% |
LGND Breaking Stock News: Dive into LGND Ticker-Specific Updates for Smart Investing
Argus Research
7 days ago
Simply Wall St.
a month ago
Argus Research
a month ago
GlobeNewswire
a month ago
Zacks Small Cap Research
a month ago
MT Newswires
a month ago
MT Newswires
a month ago
GuruFocus.com
a month ago
The information presented on this page, "LGND Ligand Pharmaceuticals Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.